Table I.
Demographic and Clinical Data of Patients With Dengue and Demographic Data of Control Subjects
| Classification | ||||
|---|---|---|---|---|
| Controls (n = 10) | Dengue without warning signs (n = 27) | Dengue with warning signs (n = 20) | Severe dengue (n = 15) | |
| Demographic data | ||||
| Age in years (mean ± SD) | 38.4 ± 16.5 | 38.4 ± 16.5 | 40.7 ± 16.1 | 40.4 ± 19.6 |
| Gender (F:M) | 8:2 | 10:17 | 13:7 | 7:8 |
| Illness day (mean ± SD)a | — | 4.2 ± 2.4 | 3.8 ± 2.6 | 4.5 ± 2.2 |
| DENV‐1:DENV‐2b | — | 1:10 | 4:7 | 0:4 |
| Clinical findings | ||||
| Bleedingc (%) | 0 | 0 | 35 | 66.7 |
| Plasma leakaged (%) | 0 | 0 | 0 | 46.2 |
| Hypotensione (%) | 0 | 0 | 0 | 25 |
SD, standard deviation.
a
Illness day corresponds to the day the patient was enrolled after fever onset.
b
DENV‐1:DENV‐2 corresponds to a proportion of dengue virus isolations and/or dengue virus genome amplifications.
c
Bleeding includes skin hemorrhage, epistaxis, gingival hemorrhage, gastrointestinal hemorrhage, urinary tract hemorrhage, and metrorrhagia.
d
Plasma leakage manifested by pleural effusion, pericardial effusion, and ascites.
e
Hypotension defined by pulse pressure below 20 mm Hg and/or hypotensive for age.